Target intelligence / Profile preview

Sialate:O-sulfotransferase 2 (WSCD2)

Target
WSCD2
Molecular classification
Enzyme, Protein-coding gene
01

Overview

Sialate:O-sulfotransferase 2 (WSCD2) is a protein-coding enzyme located on human chromosome 12. It catalyzes the transfer of a sulfate group to the 8-O position of sialic acid residues within glycoproteins, prominently including transferrin. The enzyme uses 3'-phosphoadenosine 5'-phosphosulfate (PAPS) as a sulfate donor, resulting in formation of 8-O-sulfated Sia-glycans. WSCD2’s main molecular classification is as a sulfotransferase, and it is predicted to operate in the Golgi membrane. Although cataloged as associated with certain skin diseases and personality trait loci, there is no established role for WSCD2 as a therapeutic target, nor are there known drugs or safety concerns linked to this molecule as of 2025.

Other names
WSC domain containing 2Sialate:O-sulfotransferase 2WSCD2KIAA0789WSC domain-containing protein 2
02

Mechanism of action

If a drug were to target WSCD2, plausible mechanisms would be enzyme inhibition or modulation of glycan sulfation, but no drugs have been described with such mechanisms for this molecule. Actions would be expected to alter the level or pattern of 8-O-sulfated sialic acid glycans.

03

Biological functions

Catalyzes 8-O-sulfation of sialic acid (Sia) residues in glycoproteins, especially transferrin, using 3'-phosphoadenosine 5'-phosphosulfate (PAPS) as a sulfate donorInvolved in modification of Sia-glycans
04

Disease associations

Reported associations with Porokeratosis and Darier-White Disease (as a genetic association, not an established drug target role)GWAS studies link WSCD2 to personality traits (extraversion) and suggest possible broader roles in neurobiologyNot established as a causal or therapeutic target in major disease areas (such as cancer, inflammation, or cardiovascular disease)

Beyond the preview

Go deeper on Sialate:O-sulfotransferase 2 (WSCD2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sialate:O-sulfotransferase 2 (WSCD2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call